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Purpose: Muscle strength is an important prerequisite for adequate
lower limb function and quality of life. Lack of thigh muscle strength is
thought to play a potential role in the onset and progression of symp-
tomatic knee OA, and is currently recommended for treatment of knee
OA by the OARSI therapeutic guidelines. Force generated by the lower
limb can be measured objectively to test unilateral muscle strength,
whereas most other functional performance tests rely on both limbs.
However, it is currently unclear to what extent measurement of knee
extensor and ﬂexor strength is independent of the pain status of the
contralateral knee. The purpose of this study therefore was to deter-
mine whether pain in one knee affects the measurement of isometric
muscle strength in the contralateral limb.
Methods: We used data from the Osteoarthritis Initiative (OAI), to
explore whether isometric thigh muscle strength differs between the
asymptomatic (pain-free) knee of participants with a non-acceptable
symptom status in the contralateral knee (cases), and matched knees of
participants without pain in either knee (controls). Of the 4796 OAI
participants, 3078 had bilateral measurement of isometric muscle
strength, full demographic information available at 2-year follow-up,
and did not have end-stage radiographic (KLG4) knee OA. Of these, 312
fulﬁlled our case deﬁnition of unilateral pain: a) one knee with a
numerical rating scale (NRS) pain intensity value 4 (i.e. greater than
the patient acceptable symptoms state [PASS]) and either frequent pain
(Sx2) or infrequent pain (Sx1) during in the past 12 months; b) the
contralateral knee with an NRS intensity value of 0-1, either no pain
(Sx0) or infrequent pain (Sx1) during in the past 12 months, and a
WOMAC score of 0–1. 1027 of the 3078 participants fulﬁlled the control
deﬁnition of bilateral pain-free knees, i.e. both knees had an NRS
intensity value of 0–1, either no (or infrequent) pain during in the past
12 months (Sx0 or 1), and a WOMAC score of 0–1. Of the 312 partic-
ipants with unilateral pain, 224 could be matched to a control with the
same sex and race (White/African American), and with similar age
(5y), body height (5cm), BMI (3kg/m2) and radiographic knee OA
status (KLG 0/1 or 2/3). The maximal force [N] obtained from three
isometric measurements of extensor and ﬂexor muscle strength (Good
strength chair) at the shank during 60 knee ﬂexionwas used. The pain-
free limb in each participant with contralateral painwas comparedwith
the matched limb from a bilaterally pain-free participant.
Results: Cases with unilateral painwere 58% female, 63.9 8.9 (mean
SD) years old, and had a BMI of 28.1  4.2 kg/m2. The maximum
extensor strength of pain-free knees of participants with contralateral
knee pain (cases) was, on average, 5.2% lower (p ¼ 0.04) than that of
matched bilaterally pain-free controls (Table 1). The maximum ﬂexor
strength also was signiﬁcantly lower (7.7%, p ¼ 0.02) in cases than in
controls, whereas the difference in the physical activity score of the
elderly (PASE: 7.5%, p ¼ 0.12) did not attain statistical signiﬁcance
(Table 1). As a reference, the extensor strength in the painful limbs of
the cases (312  112 N) was signiﬁcantly (p ¼ 0.00001) lower than that
of the pain-free limb in the same participant (5.9% ¼ 19.8 N [95%
CI:28.5;11.2]), and the same applied for ﬂexor strength (123  52.8
N: difference 3.9% ¼ 5.0 N [95%CI:9.0;1.0]; p ¼ 0.01).Table 1
Muscle strength in pain-free limbs in unilaterally cases vs. bilaterally controls
Case (Mean  SD) Control (Mea
Extensor strength [N] 333  108 351  146
Flexor strength [N] 128  52.4 139  74.1
PASE-score (0–361) 148  69.2 158  83.0
Age [years] 63.9  8.9 63.8  8.8
BMI [kg/m2] 28.1  4.2 28.1  4.2Conclusions: The results suggest that isometric strength measurement
in a limb with an asymptomatic knee is not independent of the pain
status of the contralateral knee. Effects from the contralateral knee may
be conveyed by central nervous system inhibition, or from a reduction
in training status and general physical activity. Although the effect
appears relatively small for the given conditions (i.e. the contra-lateral
knee having an NRS4), it is almost as large as the difference between
painful and the painless limbs in cases with unilateral non-acceptable
knee pain.
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Purpose: Quantitative Sensory Testing (QST) is a non-invasive test
battery that assesses sensory perception of pressure, mechanical and
vibration stimuli. Pressure pain thresholds assessed at a pain free
control site prior to surgery have been shown to predict pain levels one
year after total knee replacement in patients with knee osteoarthritis
(OA). However, to our knowledge there are no data looking at associa-
tions between QST measures and response to pharmacological inter-
ventions. The aim of this study was to determine whether, in patients
with symptomatic knee OA, baseline QST measures predicted response
to treatment with intra-articular steroid therapy and whether response
was associated with change in any of the QST measures.
Methods: 32men andwomenwith symptomatic kneeOAparticipating in
an uncontrolled open label clinical trial of intra-articular steroid therapy
completed QST assessments at the injected and contralateral knees at
baseline prior to intra-articular injection of depomedrone (80 mg) with
repeat assessments after an interval of between 5 and 15 days following
the injection. Subjectswerealsoasked tocomplete thepainsubscaleof the
Knee Injury andOsteoarthritis Outcome Score (0–100 scale,worst to best)
at baseline and at the follow-up assessment. The QST assessments per-
formedat bothknees included:mechanical detection threshold (0.25–512
mN von Frey ﬁlaments), mechanical pain threshold and mechanical pain
sensitivity (8–512 mN punctate probes), dynamic mechanical allodynia
(brush and cotton bud), vibration detection (64 Hz tuning fork), pressure
pain (0–10kg/cm2 algometer) and wind-up (256 mN punctate probe).
Patients also had a tender point examination (0–18 sites). Subjects were
characterised as treatment responders or treatment non-responders at
the followupvisit using theOARSI-OMERACTcriteria.Wilcoxon rank-sum
tests were used to determine differences between responders and non-
responders in QST measures at baseline and in changes in the QST
measures following intervention.Withinperson changes inQSTmeasures
were assessed using the Wilcoxon matched-pairs signed-rank test.
Results: 11 men and 21 women (mean age 62.8 years, SD 10.2 years)
with symptomatic knee OA underwent QST assessments at the injected
and contralateral knees. Twenty one (65.6%) participants were classiﬁed
as treatment responders at follow-up. Compared to non-responders,
treatment responders had signiﬁcantly lower mean baseline mechan-
ical pain thresholds at the injected knee (73.4, SD ¼ 74.6 vs 147.6, SD ¼
112.6; p ¼ 0.022) with values for the control knee also approaching
signiﬁcance (78.5, SD ¼ 64.2 vs 123.5, SD ¼ 68.6; p ¼ 0.054), indicating
higher sensitivity to mechanical pain among the responders. None of
the other baseline QST assessments, however, differed by respondern  SD) Difference (95% Conﬁd. Int.) Paired t test
-18.2 (-35.7/-0.7) p ¼ 0.04
-10.7 (-19.9/-1.6) p ¼ 0.02
-11.8 (-24.6/1.0) p ¼ 0.12
0.1 (-0.1/0.3) p ¼ 0.30
0.0 (-0.1/0.1) p ¼ 0.77
